An overview of a cohort of South African patients with mitochondrial disorders

Journal of Inherited Metabolic Disease

Volumn 33, Issue SUPPL. 3, 2010, Pages

  Smuts, Izelle ^a   Louw, Roan ^b   Du Toit, Hanli ^b   Klopper, Brenda ^b   Mienie, Lodewyk J ^b   Van Der Westhuizen, Francois H ^b  

^a STEVE BIKO ACADEMIC HOSPITAL   (South Africa)

^b NORTH WEST UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MULTIENZYME COMPLEX; PYRUVATE DEHYDROGENASE COMPLEX;

ADOLESCENT; ADULT; BLACK PERSON; CASE CONTROL STUDY; CAUCASIAN; CHILD; COMPARATIVE STUDY; DEFICIENCY; ENZYMOLOGY; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; INFANT; MALE; METABOLISM; MITOCHONDRIAL DISEASES; MITOCHONDRIAL ENCEPHALOMYOPATHY; MITOCHONDRIAL MYOPATHY; NEWBORN; PHENOTYPE; PRESCHOOL CHILD; PROGNOSIS; PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY; RISK FACTOR; SKELETAL MUSCLE; SOUTH AFRICA; YOUNG ADULT; ARTICLE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; NEGRO;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MITOCHONDRIAL DISEASES; MITOCHONDRIAL ENCEPHALOMYOPATHIES; MITOCHONDRIAL MYOPATHIES; MUSCLE, SKELETAL; PHENOTYPE; PROGNOSIS; PYRUVATE DEHYDROGENASE COMPLEX; PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY DISEASE; RISK FACTORS; SOUTH AFRICA; YOUNG ADULT;

EID: 84897925916     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-009-9031-8     Document Type: Article

References (25)

1. Brown MD, Starikovskaya E, Derbeneva O et al. (2002) The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup J. Hum Genet 110:130-138
2. Darin N, Oldfors A, Moslemi A-R, Holme E, Tulinius M (2001) The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities. Ann Neurol 49:377-383
3. Debray F, Lambert M, Chevalier I et al. (2007) Long-term outcome and clinical spectrum of 73 pediatric patients with mitochondrial disease. Pediatrics 119:722-733
4. Herrnstadt C, Howell N (2004) An evolutionary perspective on pathogenic mtDNA mutations: Haplogroup associations of clinical disorders. Mitochondrion 4:791-798
5. Janssen AJM, Trijbels FJM, Sengers RCA et al. (2007) Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. Clin Chem 53:729-734
6. Jooste S, Erasmus E, Mienie LJ et al. (1994) The detection of 3-methylglutarylcarnitine and a new dicarboxylic conjugate, 3- methylglutaconylcarnitine, in 3-methylglutaconic aciduria. Clin Chim Acta 230:1-8
7. Khusnutdinova E, Gilyazova I, Ruiz-Pesini E et al. (2008) A mitochondrial etiology of neurodegenerative diseases: evidence from Parkinson's disease. Ann N Y Acad Sci 1147:1-20
8. Lawn JE, Kinney MV (2009) Health in South Africa: An executive summary for The Lancet series. Lancet http://download.thelancet.com/flatcontentassets/ series/sa/sa-execsum.pdf
9. Loots DT, Mienie LJ, Erasmus E (2007) Amino-Acid depletion induced by abnormal amino-Acid conjugation and protein restriction in isovaleric acidemia. Eur J Clin Nutr 61:1323-1327
10. Munnich A, Rustin P (2001) Clinical spectrum and diagnosis of mitochondrial disorders. Am J Med Genet (Semin Med Genet) 106:4-17
11. Munnich A, Rötig D, Chretien V et al. (1996) Clinical presentation of mitochondrial disorders in childhood. J Inher Metab Dis 19:521-527
12. Nissenkorn A, Zeharia A, Lev D et al. (1999) Multiple presentation of mitochondrial disorders. Arch Dis Child 81:209-215
13. Rahman S, Blok RB, Dahl HH et al. (1996) Leigh Syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol 39:343-351
14. Scaglia F, Towbin JA, Craighen WJ et al. (2004) Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics 114:925-931
15. Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF (2004) The epidemiology of mitochondrial disorders-past, present and future. Biochim Biophys Acta 1659:115-120
16. Sciacco M, Prelle A, Comi GP et al. (2001) Retrospective study of a large population of patients affected with mitochondrial disorders: clinical, morphological and molecular genetic evaluation. J Neurol 248:778-788
17. Sewell AC (2008) Oligosaccharides. In: Blau N, Duran M, Gibson KM (eds) Laboratory guide to the methods in biochemical genetics. Springer-Verlag, Berlin, pp 325-333
18. Sheather SJ, Marron JS (1990) Kernel quantile estimators. J Am Stat Assoc 85:410-416
19. Shepherd D, Garland PB (1969) the kinetic properties of citrate synthase from rat liver mitochondria. Biochem J 114:597-610
20. Skladal D, Sudmeier C, Konstantopoulou V et al. (2003a) The clinical spectrum of mitochondrial disease in 75 pediatric patients. Clin Pediatr 42:703-710
21. Skladal D, Halliday J, Thorburn DR (2003b) Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126:1905-1912
22. Smeitink J (2003) Mitochondrial disorders: clinical presentation and diagnostic dilemmas. J Inherit Metab Dis 26:199-207
23. Statistics South Africa (2009) Mid-year population estimates. Stat Release P0302:1-17, Retrieved from http://www.statssa.gov.za/publications/P0302/ P03022009.pdf on 23 September 2009
24. Van Rooyen JP, Mienie LJ, Erasmus E et al. (1994) Urinary excretion of homocitric acid and methylhomocitric acid in propionic acidaemia: minor metabolic products of the citrate synthase aldol condensation reaction. Clin Chim Acta 230:91-99
25. Wolf NI, Smeitink JAM (2002) Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children. Neurology 59:1402-1405